Share price
₹80.6 latest close · +12.9% over the last 90 sessions
₹80.6 month-end · +0.2% over 12 months
₹80.6 month-end · −39.3% over 3 years
₹80.6 month-end · +231.0% since Jan '19
52-week range ₹44.10 to ₹96.00 · 1-year volatility 46.0%
How rough has the ride been?
Drawdown from peak
Largest drawdowns
-82.3% (2021-12 peak to 2026-03 low, not yet recovered)
-69.8% (2019-04 peak to 2020-03 low, recovered 2021-04)
-29.2% (2021-05 peak to 2021-06 low, recovered 2021-07)
Where does it rank among Health Technology peers?
Each cell is the company's percentile rank among its Health Technology peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Where it ranks today
- ROCE5th▼ 28 pts vs a year ago
- Op. margin32ndflat vs a year ago
- Revenue growth12th▼ 68 pts vs a year ago
- EPS growth4th▼ 96 pts vs a year ago
- Debt/equity ↓20th▼ 14 pts vs a year ago
- Cash cycle ↓80th▲ 15 pts vs a year ago
- P/E ↓6thflat vs a year ago
- 12M momentum42nd▲ 34 pts vs a year ago
Rank history
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Health Technology sector page Watch it move against Health Technology in the Observatory
What is the price implying?
Trailing earnings per share are negative, so a P/E-based figure does not exist. See the loss-makers list on the Expectations Gap page for a revenue-based version.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Health Technology The market-wide Expectations lists
Key figures
- Share Priceclose 9 Nov
- ₹80.60
- ROCE
- -6.0%
- Market Cap
- ₹291 cr
- Revenue (TTM)
- ₹138 cr
- P/S
- 2.1x
- P/B
- 3.1x
- ROE
- -9.7%
- Operating Margin
- 10.8%
- Debt / Equity
- 0.5x
- Promoter Holding
- 58.5%
- 12M Momentum
- 0.2%
52-week range
Price risk
Balance sheet & cash
Are profits backed by cash?
Other income reliance—Not enough data
Not enough reported data to compute this.
Tax rate—Not enough data
Not enough reported data to compute this.
Cash conversion—Not enough data
Not enough reported data to compute this.
Free cash flow2 of 5 yrsNear threshold
Fiscal years with positive free cash flow in the last 5: 2. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history+11 daysWithin range
Debtor days are above the median of the previous three fiscal years by 11 days (100 vs 89). Bands: under 15 days, 15 to 45, over 45.
Capital work in progress2% of fixed assetsWithin range
Capital work-in-progress is 2% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days+24 days / 2 yrsWithin range
Days payable changed by +24 over two years. Bands: rise of up to 30 days; more than 30 days.
Tap a check to see how it is measured
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
Who has been buying and selling?
- Over 3 years, promoters added 3.6 pts.
- The number of shareholders rose from 26,652 to 29,369 (+10%) between Sep 2023 and Jun 2026.
Holdings, Jun '26
How each group changed
Number of shareholders
Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.
What happened next to similar setups
- We found 50 past situations where a non-financial company looked like LYKA LABS LTD today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
- Over the following 12 months the middle half of them returned −24% to +48% vs the market, against −1% for all non-financial companies in the same months.
- The gap against the base rate (+3.4%, 80% range −8.7% to +8.5%) is within what chance and overlapping periods produce.
Where the 50 outcomes landed
Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 4 beyond the range shown, drawn at the edge
50 past situations · 50 companies · 39 months · 2020–2025
The closest matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| ATULAUTO Consumer Durables |
Dec 2022 | — | -6% | +47% | −13% | +60% |
| SHALPAINTS Process Industries |
Feb 2023 | — | -7% | +18% | −18% | −22% |
| AURIONPRO Technology Services |
Apr 2022 | — | -8% | +101% | −10% | +7% |
| SDBL Consumer Non-Durables |
May 2022 | — | -4% | +35% | −11% | +235% |
| SPECIALITY Consumer Services |
Jul 2021 | — | -8% | +135% | −2% | +133% |
Show the other 3 matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| INDTERRAIN Consumer Non-Durables |
Dec 2021 | — | -10% | +73% | −10% | +8% |
| VITAL Process Industries |
Feb 2025 | — | 0% | −11% | −33% | −42% |
| VIPCLOTHNG Consumer Non-Durables |
Sep 2020 | — | -8% | +5% | −18% | +5% |
How reliable is this?
Matched on P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: drawdown from 12-month high, 12-month momentum and revenue growth. Not used (unavailable for this company): P/E. This company is loss-making, so it was only compared with loss-making companies. One match per company and at most 7 from any one month.
Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.
What changed?
30 events since Apr '21
- SepPeer rankMoved into the 3rd quartile of Health Technology on operating margin (from the bottom quartile).
- JunPeer rankSlipped to the bottom quartile of Health Technology on ROCE (from the 3rd quartile).
- MarResultsEPS (TTM) turned negative.
- MarPriceFell 82% from the Dec 2021 peak to the Mar 2026 low.
- JanDebtDebt / equity halved over 12 months to 0.37x.
- DecResultsYear-on-year EPS growth turned negative.
- DecPeer rankSlipped to the bottom quartile of Health Technology on operating margin (from the 3rd quartile).
- SepPeer rankMoved into the top quartile of Health Technology on EPS growth (from the bottom quartile).
Show 22 earlier events
- AugSharesShare count is up 9.1% over 12 months.
- JunPeer rankMoved into the 3rd quartile of Health Technology on ROCE (from the bottom quartile).
- JunDebtDebt / equity halved over 12 months to 0.37x.
- SepPromoterPromoter holding rose 3.3 pts to 58.1%.
- SepResultsEPS (TTM) turned positive.
- SepPeer rankMoved into the 3rd quartile of Health Technology on operating margin (from the bottom quartile).
- JulSharesShare count is up 6.5% over 12 months.
- JunDebtDebt / equity fell below 1.0x (0.87x).
- JanDebtDebt / equity halved over 12 months to 1.63x.
- JunResultsEPS (TTM) turned negative.
- JunPeer rankSlipped to the bottom quartile of Health Technology on ROCE (from the top quartile).
- JunDebtDebt / equity halved over 12 months to 1.63x.
- JunSharesShare count is up 6.9% over 12 months.
- JunResultsEPS (TTM) turned positive.
- JunPeer rankMoved into the top quartile of Health Technology on ROCE (from the 3rd quartile).
- NovPriceRegained the 2021-08 peak, 3 months after the low.
- AugPriceFell 29% from the Aug 2021 peak to the Aug 2021 low.
- JulPriceRegained the 2021-05 peak, 1 month after the low.
- JunResultsRevenue (TTM) reached a new high of ₹86 cr.
- JunPriceFell 29% from the May 2021 peak to the Jun 2021 low.
- JunPeer rankMoved into the 3rd quartile of Health Technology on ROCE (from the bottom quartile).
- AprPriceRegained the 2019-04 peak, 13 months after the low.
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Monthly history95 months · 2019-01 to 2026-11
| Month | P/E | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|---|
| 2026-11 | — | ₹138 cr | -9.7% | -6.0% | 0.5x |
| 2026-10 | — | ₹138 cr | -9.7% | -6.0% | 0.5x |
| 2026-09 | — | ₹138 cr | -9.7% | -6.0% | 0.5x |
| 2026-08 | — | ₹128 cr | -10.8% | -6.0% | 0.5x |
| 2026-07 | — | ₹128 cr | -10.8% | -6.0% | 0.5x |
| 2026-06 | — | ₹128 cr | -10.8% | -6.0% | 0.5x |
| 2026-05 | — | ₹134 cr | -0.6% | 10.0% | 0.4x |
| 2026-04 | — | ₹134 cr | -0.6% | 10.0% | 0.4x |
| 2026-03 | — | ₹134 cr | -0.6% | 10.0% | 0.4x |
| 2026-02 | 107.5x | ₹137 cr | 2.0% | 10.0% | 0.4x |
| 2026-01 | 123.7x | ₹137 cr | 2.0% | 10.0% | 0.4x |
| 2025-12 | 130.8x | ₹137 cr | 2.0% | 10.0% | 0.4x |
| 2025-11 | 38.1x | ₹141 cr | 7.0% | 10.0% | 0.4x |
| 2025-10 | 44.6x | ₹141 cr | 7.0% | 10.0% | 0.4x |
| 2025-09 | 45.5x | ₹141 cr | 7.0% | 10.0% | 0.4x |
| 2025-08 | 44.2x | ₹139 cr | 7.2% | 10.0% | 0.4x |
| 2025-07 | 51.6x | ₹139 cr | 7.2% | 10.0% | 0.4x |
| 2025-06 | 51.1x | ₹139 cr | 7.2% | 10.0% | 0.4x |
| 2025-05 | 108.6x | ₹133 cr | 5.4% | 4.0% | 0.9x |
| 2025-04 | 98.8x | ₹133 cr | 5.4% | 4.0% | 0.9x |
| 2025-03 | 89.7x | ₹133 cr | 5.4% | 4.0% | 0.9x |
| 2025-02 | 116.0x | ₹132 cr | 4.4% | 4.0% | 0.9x |
| 2025-01 | 165.6x | ₹132 cr | 4.4% | 4.0% | 0.9x |
| 2024-12 | 175.4x | ₹132 cr | 4.4% | 4.0% | 0.9x |
| 2024-11 | 984.7x | ₹118 cr | 0.8% | 4.0% | 0.9x |
| 2024-10 | 906.6x | ₹118 cr | 0.8% | 4.0% | 0.9x |
| 2024-09 | 911.7x | ₹118 cr | 0.8% | 4.0% | 0.9x |
| 2024-08 | — | ₹111 cr | -3.9% | 4.0% | 0.9x |
| 2024-07 | — | ₹111 cr | -3.9% | 4.0% | 0.9x |
| 2024-06 | — | ₹111 cr | -3.9% | 4.0% | 0.9x |
| 2024-05 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2024-04 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2024-03 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2024-02 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2024-01 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2023-12 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2023-11 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2023-10 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2023-09 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2023-08 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2023-07 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2023-06 | — | ₹93 cr | -27.1% | 5.0% | 1.6x |
| 2023-05 | 7.0x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2023-04 | 7.6x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2023-03 | 7.7x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2023-02 | 8.4x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2023-01 | 9.7x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2022-12 | 9.5x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2022-11 | 10.3x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2022-10 | 10.2x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2022-09 | 9.2x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2022-08 | 11.0x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2022-07 | 9.6x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2022-06 | 8.2x | ₹194 cr | 260.6% | 61.0% | 9.3x |
| 2022-05 | — | ₹86 cr | — | 10.0% | — |
| 2022-04 | — | ₹86 cr | — | 10.0% | — |
| 2022-03 | — | ₹86 cr | — | 10.0% | — |
| 2022-02 | — | ₹86 cr | — | 10.0% | — |
| 2022-01 | — | ₹86 cr | — | 10.0% | — |
| 2021-12 | — | ₹86 cr | — | 10.0% | — |
| 2021-11 | — | ₹86 cr | — | 10.0% | — |
| 2021-10 | — | ₹86 cr | — | 10.0% | — |
| 2021-09 | — | ₹86 cr | — | 10.0% | — |
| 2021-08 | — | ₹86 cr | — | 10.0% | — |
| 2021-07 | — | ₹86 cr | — | 10.0% | — |
| 2021-06 | — | ₹86 cr | — | 10.0% | — |
| 2021-05 | — | ₹61 cr | — | -6.0% | — |
| 2021-04 | — | ₹61 cr | — | -6.0% | — |
| 2021-03 | — | ₹61 cr | — | -6.0% | — |
| 2021-02 | — | ₹61 cr | — | -6.0% | — |
| 2021-01 | — | ₹61 cr | — | -6.0% | — |
| 2020-12 | — | ₹61 cr | — | -6.0% | — |
| 2020-11 | — | ₹61 cr | — | -6.0% | — |
| 2020-10 | — | ₹61 cr | — | -6.0% | — |
| 2020-09 | — | ₹61 cr | — | -6.0% | — |
| 2020-08 | — | ₹61 cr | — | -6.0% | — |
| 2020-07 | — | ₹61 cr | — | -6.0% | — |
| 2020-06 | — | ₹61 cr | — | -6.0% | — |
| 2020-05 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2020-04 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2020-03 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2020-02 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2020-01 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2019-12 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2019-11 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2019-10 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2019-09 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2019-08 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2019-07 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2019-06 | — | ₹71 cr | -13.4% | -5.0% | 2.2x |
| 2019-05 | — | ₹60 cr | -37.2% | -8.0% | 2.3x |
| 2019-04 | — | ₹60 cr | -37.2% | -8.0% | 2.3x |
| 2019-03 | — | ₹60 cr | -37.2% | -8.0% | 2.3x |
| 2019-02 | — | ₹60 cr | -37.2% | -8.0% | 2.3x |
| 2019-01 | — | ₹60 cr | -37.2% | -8.0% | 2.3x |